SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
184	8	0	SANG

Emcee: Carson O. Ray, Jr.	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
34	<Do you have a link to that press release?> Don- The information was fr	SteveG	-	5/3/1997
33	Thanks Carson for the info.	Don Knudsen	-	5/3/1997
32	Don: I don't have the link handy, but I copied into my SANG "files&qu	Carson O. Ray, Jr.	-	5/2/1997
31	<That SANG used Neoral (as opposed to SandImmune) as the bioequivalent&g	Don Knudsen	-	5/2/1997
30	Steave, I do agree with you that this stock is undervalued. Vector Securities	Jeffers Hughes	-	4/29/1997
29	John- <-- The numbers on the percentage of assets held by mutual funds in c	SteveG	-	4/29/1997
28	Hi Carson- <As near as I can tell, this is only their clinical evidence pre	SteveG	-	4/28/1997
27	Re. Novartis & suits: Correct any of my misunderstandings, anyone, but Nova	Carson O. Ray, Jr.	-	4/28/1997
26	Hi Carson- Sorry, I didn't read the SANG thread until just recently. <	SteveG	-	4/28/1997
25	Steve -- The numbers on the percentage of assets held by mutual funds in cash i	John B. Anderson	-	4/28/1997
24	SANG is flush with cash-$120M. A stock I hold, ADRX, has 2 similar suits for t	James Silverman	-	4/28/1997
23	Jonathon - Good point - my understanding is these pharmaceutical legal battles	Chris Baker	-	4/28/1997
22	All, SANG "was" the number one ranked biomedical stock according to	John Veltheer	-	4/27/1997
21	4/27 Inv's Bus. Daily said in a note regarding SANG's drop that H&Q	Carson O. Ray, Jr.	-	4/27/1997
20	Sometimes delays are good, especially for small companies trying to work throug	Jonathan Rothschild	-	4/26/1997
19	Carson - I suspect that some traders already knew some delays were coming up an	Chris Baker	-	4/26/1997
18	4/25 Inv's. Bus. Daily when mentioning the SANG drop, said that H/Q had low	Carson O. Ray, Jr.	-	4/26/1997
17	I don'y think analysts in other firms will give such a low 12 month target.	Jeffers Hughes	-	4/26/1997
16	How can they target a 19 for a company with two products under FDA review.	Jeffers Hughes	-	4/26/1997
15	Hi John- <Carson -- Thanks for your detailed information...> I second t	SteveG	-	4/26/1997
14	Carson -- Thanks for your detailed information on what the analysts at UBS wer	John B. Anderson	-	4/25/1997
13	UBS Securities says HOLD As you probably have read by now: UBS Securites said	Carson O. Ray, Jr.	-	4/25/1997
12	John - My guess is that the company's trial drugs were viewed as not as str	Chris Baker	-	4/25/1997
11	Todays news: quote.yahoo.com ------------------------------------------------	SteveG	-	4/25/1997
10	Hi John- <heard any rumors to explain it?> Yesterday's news (below)	SteveG	-	4/25/1997

Go to reply# or date (mm/dd/yy):